Tuesday, February 23, 2010

Internal Medicine Residencies and Pharma Money: We Don't Like It but We Take It

›
Duff Wilson in the New York Times : http://www.nytimes.com/2010/02/23/business/23docs.html --offered a handy synopsis of a paper by Dr. Laur...
5 comments:

NPR: More Details on the Obama-PhRMA Back Room Deal

›
A while back we noted the possible connection between Billy Tauzin's departure as president of PhRMA and the deal the lobbying organizat...

The Secret Avandia Tapes: Comedy or Smoking Gun?

›
Gardiner Harris broke this story yesterday in the New York Times : http://www.nytimes.com/2010/02/23/health/23niss.html My own opinion is th...
Sunday, February 21, 2010

The Avandia Story: Failures of Regulation and Professionalism

›
Rosiglitazone (Avandia) is back in the news. First I opened my newspaper this morning to read the following article: http://hosted.ap.org/dy...
1 comment:
Friday, February 19, 2010

Latest from the Bonkers Institute: Why Didn't Pharma Marketers Think of This?

›
Those wishing a chuckle should check out the recent report from the Bonkers Institute for Nearly Genuine Research: http://www.bonkersinstitu...
2 comments:
Saturday, February 13, 2010

Departure of the Two Million Dollar Man--A Blow to Reform?

›
On a speaking trip to LA, I belatedly opened yesterday's edition of the Los Angeles Times to encounter Tom Hamburger's detailed rep...
Wednesday, February 10, 2010

Big Pharma's Sacrifice for Health Reform--Not

›
Today's Houston Chronicle features a hard-hitting editorial-- http://www.chron.com/disp/story.mpl/editorial/6859351.html --detailing a ...